If you are wondering what health care disparities might look like in medication use for chronic diseases, a new study published in JAMA Network Open can serve as just one example.

Loren Bonner

On May 27, FDA expanded the indication for rimegepant (Nurtec ODT—Biohaven) to include preventive treatment in adults with episodic migraine, defined as fewer than 15 headache days per month.

Cara Aldridge Young

In today’s climate of self-management for optimal health and wellness, use of prebiotics and probiotics has become increasingly popular.

Daniel L. Krinsky, RPh, MS

Many patients with chronic pain turn to alternative, complementary therapy as part of their pain management. Acupuncture has been gaining legitimacy for decades and was approved as a medical therapy in the United States in the 1990s.

Mickie Cathers

Updates from FDA

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), constipation is defined as having fewer than three bowel movements a week; stools that are hard, dry, or lumpy; stools that are difficult or painful to pass; or a feeling that not all stool has passed.

Mary Warner

Beetroot juice is well-known in the sports community as a postworkout must and performance enhancer.

Mickie Cathers

After 5 years with no breakthroughs for patients living with amyotrophic lateral sclerosis (ALS), FDA has approved a new oral treatment called Relyvrio from Amylyx Pharmaceuticals.

Lauren Howell, PharmD

This fall, biotech Biogen and pharmaceutical company Eisai released topline data on their new antiamyloid monoclonal antibody le-canemab.

Sonya Collins